|
AIDS Patient Care and STDs
Age of Menopause and Menopausal Symptoms in HIV-Infected Women
To cite this article:
Lori E. Fantry, Min Zhan, Gregory H. Taylor, Anne M. Sill, Jodi A. Flaws.
AIDS Patient Care and STDs.
November 2005,
19(11): 703-711.
doi:10.1089/apc.2005.19.703.
Lori E. Fantry, M.D., M.P.HUniversity of Maryland Medical School, Baltimore, Maryland. Institute of Human Virology, Baltimore, Maryland. Min Zhan, Ph.D.University of Maryland Medical School, Baltimore, Maryland. Gregory H. Taylor, M.D.University of Maryland Medical School, Baltimore, Maryland. Institute of Human Virology, Baltimore, Maryland. Anne M. Sill, B.A.Institute of Human Virology, Baltimore, Maryland. Jodi A. Flaws, Ph.D.University of Maryland Medical School, Baltimore, Maryland. The objective of this study was to examine the median age of menopause, factors associated with postmenopausal status, and the prevalence of menopausal symptoms in HIV-infected women. We surveyed 120 HIV-infected women between 40 and 57 years old who attended an inner city infectious diseases clinic. Ninety-five percent of the women surveyed were African American and almost half of the women (44%) had used methadone, heroin, cocaine, marijuana, or a combination of these drugs within the past 6 months. Eighty-seven percent had smoked cigarettes at least some time during their life and 45% drank alcohol between the ages of 40 and 49 years old. Thirty women were postmenopausal (having no menstrual periods in the previous 12 consecutive months), 31 were perimenopausal (having 1–11 periods within the previous 12 months), and 59 were premenopausal (having 12 or more periods within the previous 12 months). The median age of menopause was 50 years old (95% confidence interval = 49, 53). In a multivariate model, methadone use within the past 6 months was associated with postmenopausal status. We did not find an association between postmenopausal status and body mass index, number of pregnancies, CD4 cell counts, HIV viral load, individual and grouped antiretroviral therapies, cigarette smoking, and current or past oral contraceptive use. In multivariate analysis, postmenopausal status was associated with hot flashes and cocaine use was associated with vaginal dryness.  This paper was cited by:Low Levels of Adherence to Antiretroviral Therapy in HIV-1–Infected Women with Menstrual Disorders Carmina R. Fumaz, Jose A. Muñoz-Moreno, María José Ferrer, Eugenia Negredo, Núria Pérez-Álvarez, Antoni Tarrats, Bonaventura Clotet AIDS Patient Care and STDs. Jun 2009, Vol. 23, No. 6: 463-468 Abstract | Full Text PDF | Reprints & PermissionsHIV, reproductive aging, and health implications in women Délio Marques Conde, Emanuela T. Silva, Waldemar N. Amaral, Marta F. Finotti, Rui G. Ferreira, Lúcia Costa-Paiva, Aarão M. Pinto-Neto Menopause. Feb 2009, Vol. 16, No. 1: 199-213 CrossRef Attribution of menopause symptoms in human immunodeficiency virus-infected or at-risk drug-using women Tonya M. Johnson, Hillel W. Cohen, Andrea A. Howard, Nanette Santoro, Michelle Floris-Moore, Julia H. Arnsten, Diana M. Hartel, Ellie E. Schoenbaum Menopause. Jun 2008, Vol. 15, No. 3: 551-557 CrossRef HIV and Menopause: A Review Erna Milunka Kojic, Chia-Ching Wang, Susan Cu-Uvin Journal of Women's Health. Dec 2007, Vol. 16, No. 10: 1402-1411 Abstract | Full Text PDF | Reprints & PermissionsEffects of age and sex on immunological and virological responses to initial highly active antiretroviral therapy K Patterson, S Napravnik, J Eron, J Keruly, R Moore HIV Medicine. Oct 2007, Vol. 8, No. 6: 406-410 CrossRef Important considerations regarding antiretroviral therapy in HIV-positive women Denise Jaworsky, Tony Antoniou, Mona R Loutfy Future HIV Therapy. Aug 2007, Vol. 1, No. 2: 203-213 CrossRef
|
|